The results described in this investigation expand our knowledge of multipotent compounds by showing the possibility of the 4-(trifluoromethylphenyl)hydrazono-substituted furochromone 3e concurrently inhibiting several targets involved in AD, namely, ChEs, BACE-1, COX, and LOX, including oxidative stress. This evidence concerns the gene LOX and Alzheimer disease.